Try our Advanced Search for more refined results

FTC Says Patent Infringement Suits Are Not Antitrust Proof

By Bryan Koenig ( June 7, 2018, 7:01 PM EDT) -- Takeda Pharmaceutical Co. Ltd. can't dodge antitrust counterclaims from generic drugmaker Zydus Pharmaceuticals (USA) Inc. simply by arguing that it is allowed to sue generics companies for patent infringement when they seek approval to copy branded products, the Federal Trade Commission told a New Jersey federal judge in a proposed amicus brief on Wednesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!